Corden Pharma Experts taking care. APIs DRUG PRODUCTS FACILITIES PLATFORMS ABOUT US CONTACT US News and Press Home About Us News and Press CordenPharma Colorado Named Among Top Places to Work Apr 28, 2014 The Denver Post recently named CordenPharma Colorado as one of the Top Places to Work in Colorado. CordenPharma Switzerland Transfers Amino Acid Building Blocks Portfolio to Chemie Uetikon GmbH Feb 21, 2014 Effective February 1, 2014, CordenPharma Switzerland transfers their Amino Acid Building Blocks portfolio to Chemie Uetikon GmbH, based in Lahr, Germany CordenPharma Colorado Receives Potent Compound Safety Certification Approval from SafeBridge® Jan 27, 2014 CordenPharma Colorado announces receipt of approval for the "Potent Compound Safety Certification" by SafeBridge® Consultants, Inc. for the safe handling of potent APIs and compounds of unknown toxicity and potency. CordenPharma Acquires Ancora's Carbohydrate Synthesis Platform Nov 01, 2013 On October 31, 2013 CordenPharma acquired Ancora Pharmaceuticals, located in Woburn, MA, USA. Ancora’s unique carbohydrate synthesis technology platform and chemistry research facilities perfectly complement CordenPharma’s capabilities in the manufacture and supply of high-quality complex synthetic molecules. ICIG to acquire Allessa from Cassella Sep 25, 2013 International Chemical Investors Group (ICIG) and Casella GmbH have reached an agreement in principle under which ICIG would acquire all of the shares of Allessa GmbH. Both parties have agreed not to disclose the purchase price. CordenPharma Caponago Granted SHE Certification Sep 03, 2013 CordenPharma Caponago was recently granted SHE Certification with an OH SAS 18001:2007 Certificate for the maintenance of their Safety Management System involving manufacturing activities and the packaging and control of injectable liquid, freeze-dried and powder products. CordenPharma to Acquire Peptisyntha from Solvay Aug 28, 2013 International Chemical Investors Group (ICIG) and the Solvay Group have entered into an agreement under which ICIG will acquire Peptisyntha SA, the Brussels, Belgium, based custom manufacturer of peptides for pharmaceutical use. Upon closing of the deal, expected later this fall, Peptisyntha will become a member of ICIG’s CordenPharma platform as its third site offering peptides manufacturing. CordenPharma Colorado Boosts Boulder as Innovation Hub Jun 13, 2013 In an article on June 7th of The Boulder County Business Report, the city of Boulder, Colorado was cited for national recognition as an innovation hub in various informal polls. ICIG Announces New CordenPharma Management Team Jun 03, 2013 ICIG announced today changes in the management of CordenPharma, its pharmaceutical contract manufacturing business. What Does it Take to Produce 25 kg of Peptides? May 06, 2013 Visit our upcoming poster Development of a Scalable Process for CNP-22, presented by Valerie Paulsen, Principal Analytical Chemist, CordenPharma Colorado at Tides 2013, May 12 - 15 in Boston. Interview of CordenPharma Colorado's Brad DeHoff by Phenomenex Apr 05, 2013 In a recent issue of their e-newslettter PrepLC eNews, the R&D staff at Phenomenex interviews Dr. Brad DeHoff, Director of R&D for CordenPharma Colorado, about current and future trends of the CMO industry. ICIG kicks off €50+ million investment at PPC in Thann, France Mar 22, 2013 International Chemical Investors Group (ICIG) kicks off €50+ million investment at PPC, a company of WeylChem Group, the fine chemicals platform of ICIG, to develop membrane-based technology. PPC is located in Thann, France. CordenPharma Colorado Named Approved Peptide Supplier for Linaclotide Mar 08, 2013 In an article published on March 4th in Chemical & Engineering News, CordenPharma Colorado was named an approved peptide supplier to Ironwood Pharmaceuticals for their product Linaclotide: CordenPharma Colorado Regional Science Fair 2013 Mar 05, 2013 On Thursday, February 28th CordenPharma Colorado sponsored and sent 3 scientists to serve as jurors for the CordenPharma Colorado Regional Science Fair, which took place at on the University of Colorado campus in Boulder. CordenPharma Expands with ICIG Acquisition of Farchemia Feb 13, 2013 CordenPharma announces an expansion of manufacturing capabilities due to the recent acquisition by International Chemical Investors Group (ICIG) of Farchemia from the Tessenderlo Group, completed on December 5th, 2012. CordenPharma Chenôve Receives Certificates from Japan PDMA and French ANSM Dec 13, 2012 CordenPharma Chenôve receives updated certificate of compliance to cGMP standards from the PDMA in Japan and the ANSM in France. CordenPharma Caponago Receives WCA Achievement Award Nov 30, 2012 CordenPharma Caponago Receives Workplace Conditions Assessment (WCA) Achievement Award Enabled by Intertek. Orifarm Generics Names CordenPharma Best Supplier Oct 24, 2012 Today Orifarm Generics announced that CordenPharma was elected as the Best Supplier in the Orifarm Generics' Supplier Evaluation 2012. CordenPharma Presents European Outsourcing Award at CPhI 2012 Oct 10, 2012 CordenPharma presents the award for the Most Effective Process Development/Scale-Up Programme at the European Outsourcing Awards on October 10th in Madrid during CPhI 2012. And the winner is.... Tessenderlo Group Intention to Sell Pharmaceutical Ingredients Activities Oct 09, 2012 Tessenderlo Group (NYSE Euronext: TESB) announced today that it has the intention to sell its pharmaceutical ingredients activities, Farchemia and Calaire Chimie, to International Chemical Investors Group (ICIG), a private industrial holding company. The sale concerns two production sites in France and Italy. CordenPharma Paclitaxel Approved in Europe Oct 05, 2012 Today CordenPharma announced the approval of our proprietary generic drug product dossier for Paclitaxel in the reference state (Germany). With this approval CordenPharma is now open to out-licensing the generic Paclitaxel dossier with rights to register, promote and market the drug to esteemed customers in all EU territories. CordenPharma to Sponsor Boulder Peptide Symposium 2012 Aug 09, 2012 CordenPharma will be Gold Sponsors of the Boulder Peptide Symposium, taking place September 26-28, 2012 at the St. Julien Hotel and Spa in Boulder, CO. Read the full story for Discounted Registration Information. CordenPharma Colorado Named Among Top 50 Businesses in Boulder Jul 31, 2012 In the Boulder Daily Camera's annual list of Top 50 Largest Businesses, CordenPharma Colorado ties with Google Inc. at Number 42 ~ click here for the Daily Camera's full article. Frost & Sullivan Acclaims CordenPharma for Achieving Excellence in Product Differentiation Feb 16, 2012 Based on its recent analysis of the pharmaceutical contract manufacturing market, Frost & Sullivan recognises CordenPharma with the 2011 Western Europe Frost & Sullivan Award for Product Differentiation Excellence. International Chemical Investors Group Announces Acquisition of CordenPharma Colorado from Roche Oct 06, 2011 We are pleased to announce that on September 1, 2011 International Chemical Investors Group (ICIG) acquired a former division of Roche to join their pharmaceutical platform CordenPharma International as CordenPharma Colorado. International Chemical Investors Group Announces Agreement to Acquire Pharmaceutical Intermediates Business from Genzyme Corporation Feb 03, 2011 Luxembourg – International Chemical Investors Group (ICIG) announced that it has entered into a purchase agreement under which an affiliate of ICIG will acquire the pharmaceutical intermediates business from Genzyme Corporation. About Us Our History Compliance News and Press Events ICIG Careers Resource Library » Standard Catalog Products Brochures Corden Pharma Corden Pharma International GmbH, Otto-Hahn-Strasse, 68723 Plankstadt, Germany sales@cordenpharma.com ©2012 CordenPharma International Media Contact Impressum Terms and Conditions Privacy Policy Website by Boston Interactive Facebook LinkedIn APIs API Development API Contract Manufacturing Generic API Manufacturing Highly Potent APIs Sterile APIs Peptides Building Blocks Conjugate Products Carbohydrates Derivatized Phospholipids Support Services Drug Products Drug Product Development Drug Product Contract Manufacturing Generic Drug Manufacturing Sterile Formulation Highly Potent Formulation Oncology Cephalosporin Manufacturing Penicillin Manufacturing Parenterals Large Pre-Filled Syringes Sterile Oncology Oral Oncology Two-layer tablets Clinical Supply Services Packaging Pharma-Logistics Support Services Facilities Bergamo, IT Brussels, BE Caponago, IT Chenôve, FR Colorado, US Latina, IT Plankstadt, DE Liestal, CH Platforms Antibiotic / Oncology High Potent / Small Molecule Peptide / Injectable About Us Our History Compliance News and Press Events ICIG Careers Contact Us